Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
License and other revenues $ 1,346
Expenses:        
Royalties 350
Research and development 5,490 9,056 22,693 25,923
General and administrative 3,890 5,816 11,574 17,261
Impairment of licensed technology 1,355
Impairment of right-of-use lease asset 1,561
Impairment of construction-in-progress 1,792
Total expenses 9,380 14,872 39,325 43,184
Loss from operations (9,380) (14,872) (37,979) (43,184)
Gain on settlement with licensor 6,743 6,743
PPP loan payable forgiveness income 1,758 1,758
Interest income 72 7 103 35
Interest expense (157) (683) (558) (3,603)
Other income (expense) (19) 3 (136) (2)
Net loss (9,484) (7,044) (38,570) (38,253)
Deemed dividends related to Series A and Series B Convertible Redeemable Preferred Stock (3,782)
Net loss attributable to Common Shareholders $ (9,484) $ (7,044) $ (42,352) $ (38,253)
Basic and diluted loss per common share $ (1.48) $ (1.80) $ (7.05) $ (9.93)
Weighted average number of common shares outstanding – basic and diluted 6,421,245 3,924,024 6,009,902 3,853,318
Other comprehensive income (loss):        
Change in unrealized gains (losses) related to available-for-sale debt securities $ (4) $ 1 $ (11) $ 10
Foreign currency translation adjustments (6) (9) (6) (9)
Comprehensive loss $ (9,494) $ (7,052) $ (42,369) $ (38,252)